Home > News > 116/Safety and feasibility of His bundle pacing at a tertiary cardiac centre
Read Time: 2 mins

116/Safety and feasibility of His bundle pacing at a tertiary cardiac centre

Published Online: October 3rd 2008 European Journal of Arrhythmia & Electrophysiology. 2019;5(Suppl. 1):abstr116
Authors: A Merghani (Presenting Author) - Barts Heart Centre, London, UK; C Monkhouse - Barts Heart Centre, London, UK;A Jacinto - Barts Heart Centre, London, UK; J Behar - Barts Heart Centre, London, UK; S Ahsan - Barts Heart Centre, London, UK; R Providencia - Barts Heart Centre, London, UK; MD Lowe - Barts Heart Centre, London, UK; A Chow - Barts Heart Centre, London, UK; P Moore - Barts Heart Centre, London, UK; A Muthumala - Barts Heart Centre, London, UK
Quick Links:
Article Information

Introduction: Permanent His Bundle pacing has been reported as a promising alternative to conventional right ventricular and biventricular pacing due to its ability to deliver and potentially correct intrinsic His-Purkinje conduction. We performed a medium term follow up study of patients who underwent His Bundle Pacing (HBP) to examine safety, feasibility and stability of lead parameters.
Methods: HBP was performed using a Medtronic 3830 SelectSecure lead through either a Medtronic C304 deflectable guide catheter or a C315 fixed curve guide catheter. A total of 15 patients underwent HBP, including 11 (73%) males with a mean age of 71.2 ± 9 years. Thirteen patients had documented left ventricular dysfunction. ECG abnormalities included left bundle branch block (n=4), right bundle branch block (n=3), 1st degree AV block (n=2), Mobitz type 2 second degree AV block (n=2),
complete heart block (n=3) or atrial fibrillation prior to AV node ablation (n=1). All patients had a RV pacing/defibrillator lead. Patients were followed up for a mean duration of 29.1 ± 9.1 weeks.
Results: Mean fluoroscopy time was 20.2 ± 16.4 minutes and mean radiation dose was 8 mG. Selective His capture was achieved in 6 (40%) of patients. There was no statistically significant difference between the mean threshold at implant and follow up, 1.4 ± 1.69 volts at 1 ms versus 1.27 ± 1 volts at 1 ms respectively (p=0.69) (see Figure 1). Sensing was 5.3 ± 5.4 millivolts at implant with no statistically significant difference at follow-up (p=0.4). Lead impedance was also similar at implant and follow-up, 593 ± 179 Ohms versus 423 ± 68 Ohms respectively, p=0.18. There were no reported complications during all procedures and at follow up.
Conclusion: In our case series His Bundle Pacing was found to be safe, feasible and associated with stable lead parameters during follow-up. There are several potential roles for HBP in clinical practice. Randomised control studies are necessary to define these roles and assess long term clinical efficacy.

Article Information:

Further Resources

Share this Article
Related Content In Arrhythmia
43/Cardiac tamponade as a complication of transseptal puncture: associations and operatordependent variables during left atrial ablation at Barts Heart Centre
E Maclean (Presenting Author) - St Bartholomew’s Hospital, London; K Mahtani - St Bartholomew’s Hospital, London; C Butcher - St Bartholomew’s Hospital, London; N Ahluwalia - St Bartholomew’s Hospital, London; M Finlay - St Bartholomew’s Hospital, London; S Honarbakhsh - St Bartholomew’s Hospital, London; A Creta - St Bartholomew’s Hospital, London; A Chow - St Bartholomew’s Hospital, London; V Sawhney - St Bartholomew’s Hospital, London; V Ezzat - St Bartholomew’s Hospital, London; MJ Earley - St Bartholomew’s Hospital, London; M Dhinoja - St Bartholomew’s Hospital, London; S Sporton - St Bartholomew’s Hospital, London; MD Lowe - St Bartholomew’s Hospital, London; PD Lambiase - St Bartholomew’s Hospital, London; F Khan - St Bartholomew’s Hospital, London; SY Ahsan - St Bartholomew’s Hospital, London; RJ Hunter - St Bartholomew’s Hospital, London; RJ Schilling - St Bartholomew’s Hospital, London; O Sega - St Bartholomew’s Hospital, London Read Time: 2 mins

European Journal of Arrhythmia & Electrophysiology. 2021;7(Suppl. 1):abstr43

Introduction: Cardiac tamponade is a high morbidity complication of transseptal puncture (TSP). We examined the incidence and predictors of TSP-related cardiac tamponade (TRCT) for all patients undergoing left atrial ablation at our centre from 2016-2020. Methods: Patient and procedural variables were extracted retrospectively. Cases of cardiac tamponade were scrutinised to adjudicate TSP culpability. Adjusted multivariate […]

  • Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72